These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 9892228

  • 1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
    Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S.
    Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228
    [Abstract] [Full Text] [Related]

  • 2. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [Abstract] [Full Text] [Related]

  • 3. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
    Koivisto VA, Tuominen JA, Ebeling P.
    Diabetes Care; 1999 Mar; 22(3):459-62. PubMed ID: 10097929
    [Abstract] [Full Text] [Related]

  • 4. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN, Thacker CH, English J, Bethel MA, Lane JD.
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [Abstract] [Full Text] [Related]

  • 5. Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
    Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli G.
    Diabetes Care; 1996 Sep; 19(9):945-52. PubMed ID: 8875087
    [Abstract] [Full Text] [Related]

  • 6. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N, Jones TW, Holcombe J, Tamborlane WV.
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [Abstract] [Full Text] [Related]

  • 7. Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.
    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.
    Diabetes Care; 1998 Oct; 21(10):1627-31. PubMed ID: 9773721
    [Abstract] [Full Text] [Related]

  • 8. Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.
    Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT.
    Diabetes Care; 2001 May; 24(5):886-90. PubMed ID: 11347749
    [Abstract] [Full Text] [Related]

  • 9. Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes.
    Hedman CA, Orre-Pettersson AC, Lindström T, Arnqvist HJ.
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):107-12. PubMed ID: 11453959
    [Abstract] [Full Text] [Related]

  • 10. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR, Waters DL, Holcombe JH, Schade DS.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [Abstract] [Full Text] [Related]

  • 11. Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.
    Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G.
    Diabetes Care; 2003 Jul; 26(7):2027-31. PubMed ID: 12832307
    [Abstract] [Full Text] [Related]

  • 12. Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy.
    Ruggenenti P, Flores C, Aros C, Ene-Iordache B, Trevisan R, Ottomano C, Remuzzi G.
    Diabetes Care; 2003 Feb; 26(2):502-9. PubMed ID: 12547889
    [Abstract] [Full Text] [Related]

  • 13. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
    Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.
    Diabetes Metab Res Rev; 2004 Feb; 20(1):55-60. PubMed ID: 14737746
    [Abstract] [Full Text] [Related]

  • 14. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB, Home PD.
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [Abstract] [Full Text] [Related]

  • 15. Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes.
    Murase Y, Yagi K, Sugihara M, Chujo D, Otsuji M, Muramoto H, Mabuchi H.
    Intern Med; 2004 Sep; 43(9):779-86. PubMed ID: 15497510
    [Abstract] [Full Text] [Related]

  • 16. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB, Mallias J, Home PD.
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [Abstract] [Full Text] [Related]

  • 17. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
    Rassam AG, Zeise TM, Burge MR, Schade DS.
    Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
    [Abstract] [Full Text] [Related]

  • 18. Effects of regular insulin or insulin LISPRO on glucose metabolism after an oral glucose load in patients with type 2 diabetes mellitus.
    Paquot N, Roulin D, Schneiter P, Ruiz J, Lefebvre P, Pahud P, Tappy L.
    Diabetes Metab; 1998 Dec; 24(6):523-8. PubMed ID: 9932219
    [Abstract] [Full Text] [Related]

  • 19. The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.
    Joseph SE, Korzon-Burakowska A, Woodworth JR, Evans M, Hopkins D, Janes JM, Amiel SA.
    Diabetes Care; 1998 Dec; 21(12):2098-102. PubMed ID: 9839100
    [Abstract] [Full Text] [Related]

  • 20. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
    Basu R, Basu A, Nielsen M, Shah P, Rizza RA.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.